WHAT does this mean for you? I can help!
The FDA’s decision, made on 12/19, could lead to: 💲💲Patients facing higher costs and tougher access to tirzepatide, the active ingredient in Mounjaro and Zepbound. ❌A halt to cheaper copies of the drug, known as compounded tirzepatide. 💉 A precedent READ MORE
